We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

January 9, 2009

ASTRAZENECA PHARMACEUTICALS LP et al v. BIOVAIL LABORATORIES INTERNATIONAL SRL et al

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. May 2, 2011

    AstraZeneca Ends Seroquel Case Against Biovail

    A New Jersey federal judge on Monday signed off on a joint stipulation of dismissal of AstraZeneca Pharmaceuticals LP’s case alleging Biovail Corp. infringed its patents by seeking to launch a generic version of AstraZeneca’s popular treatment for bipolar disorder and schizophrenia, Seroquel XR.

2 other articles on this case. View all »

Parties

To view the parties, register now.